Fisher & Paykel Healthcare

Fisher & Paykel Healthcare

Manufacturer, designer and marketer of products.

HQ location
Auckland, New Zealand
Launch date
Market cap
$13.9b
Enterprise value
$13.8b
Share price
NZD36.61 FPH.NZ
  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
*

N/A

Post IPO Equity
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
NZD2022202320242025202620272028
Revenues0000000000000000000000000000
% growth(16 %)(3 %)11 %(27 %)75 %12 %11 %
EBITDA0000000000000000000000000000
% EBITDA margin37 %27 %21 %51 %32 %34 %35 %
Profit0000000000000000000000000000
% profit margin23 %16 %8 %29 %19 %20 %21 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue9 %11 %11 %18 %---

Source: Company filings or news article, Equity research estimates

Notes (0)
More about Fisher & Paykel Healthcare
Made with AI
Edit

What began in 1934 as an appliance import business by founders Woolf Fisher and Maurice Paykel, evolved into a global leader in medical devices. The shift into healthcare started in the late 1960s from a need identified by Dr. Matt Spence at Auckland Hospital. He saw that patients on mechanical ventilators suffered from dry tracheas and sought a solution. This led to a collaboration with engineers Alf Melville and Dave O'Hare from Fisher & Paykel Industries. The result was a prototype humidifier, ingeniously crafted from a fruit-preserving jar. Fisher & Paykel's appliance division took this prototype and turned it into a manufactured product, selling the first respiratory humidifier in 1970. This marked the company's entry into the healthcare sector, which grew steadily over the following decades. A major turning point occurred in 2001 when Fisher & Paykel Industries split its operations. Fisher & Paykel Healthcare Corporation Ltd. became a separate, publicly listed company on the New Zealand and Australian stock exchanges, a move that allowed the healthcare business to focus on its specialized market. Today, the company designs and manufactures a wide range of products for respiratory care, acute care, and the treatment of obstructive sleep apnea, sold in about 120 countries.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo